Lpl Financial LLC Provention Bio, Inc. Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$6.7 - $24.21 $95,743 - $345,960	-14,290 Reduced 29.91%	33,493 $807,000
Q4 2022 Feb 07, 2023	BUY	$4.52 - $10.57 $80,907 - $189,203	17,900 Added 59.9%	47,783 $505,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $72 - $118	21 Added 0.07%	29,883 $134,000
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $5,719 - $11,439	-1,567 Reduced 4.99%	29,862 $119,000
Q1 2022 May 16, 2022	BUY	$3.4 - $7.88 $4,001 - $9,274	1,177 Added 3.89%	31,429 $230,000
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $19,565 - $25,865	-3,500 Reduced 10.37%	30,252 $170,000
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $191,036 - $281,154	33,752 New	33,752 $216,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.